🇪🇺 Doxorubicin Hydrochloride in European Union

EMA authorised Doxorubicin Hydrochloride on 20 June 1996

Marketing authorisation

EMA — authorised 20 June 1996

  • Marketing authorisation holder: BAXTER HOLDING B.V.
  • Status: approved

Doxorubicin Hydrochloride in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Doxorubicin Hydrochloride approved in European Union?

Yes. EMA authorised it on 20 June 1996.

Who is the marketing authorisation holder for Doxorubicin Hydrochloride in European Union?

BAXTER HOLDING B.V. holds the EU marketing authorisation.